Jean-Christophe Bélisle-Pipon, PhD
Jean-Christophe Bélisle-Pipon, PhD
Petrie-Flom Center, Harvard Law School
Verified email at umontreal.ca - Homepage
TitleCited byYear
Drug Familiarization and Therapeutic Misconception Via Direct-to-Consumer Information
JC Bélisle Pipon, B Williams-Jones
Journal of Bioethical Inquiry 12 (2), 259-267, 2015
132015
Regulating Direct-to-Consumer Drug Information: A Case Study of Eli Lilly’s Canadian 40over40 Erectile Dysfunction Campaign
JC Bélisle Pipon, B Williams-Jones
Healthcare Policy 10 (4), 16-22, 2015
92015
Early-career researchers’ views on ethical dimensions of patient engagement in research
JC Bélisle-Pipon, G Rouleau, S Birko
BMC medical ethics 19 (1), 21, 2018
72018
Duty to inform and informed consent in diagnostic radiology: how ethics and law can better guide practice
V Doudenkova, JCB Pipon
HEC forum 28 (1), 75-94, 2016
62016
Ethics education in public health: where are we now and where are we going?
V Doudenkova, JC Bélisle-Pipon, L Ringuette, V Ravitsky, ...
International Journal of Ethics Education, 2017
42017
Experts sous influence? Quand la non-divulgation des conflits d’intérêts met à risque la confiance du public
B Williams-Jones, JC Bélisle-Pipon, L Ringuette, AI Cloutier, ...
Autour de l’intégrité scientifique, la loyauté, et la probité : aspects …, 2016
42016
De la binarité au modèle AI3R : la bioéthique écosystémique comme modèle d’analyse normative de l’industrie biopharmaceutique
JC Bélisle Pipon
Université de Montréal, 2013
42013
Early career researchers’ perspectives and roles in patient-oriented research
G Rouleau, JC Bélisle-Pipon, S Birko, P Karazivan, N Fernandez, ...
Research Involvement and Engagement 4 (1), 35, 2018
32018
Protecting public health or commercial interests? The importance of transparency during immunization campaigns
JC Bélisle-Pipon, L Ringuette, V Doudenkova, B Williams-Jones
Ethics, Medicine and Public Health, 2017
32017
Patients as Research Partners; How to Value their Perceptions, Contribution and Labor?
E Smith, JC Bélisle-Pipon, D Resnik
Citizen Science 4 (1), 1-13, 2019
22019
Améliorer la compréhension et la gestion des conflits d’intérêts des experts conseillant la prise de décisions en santé publique
AI Cloutier, JC Bélisle-Pipon, L Ringuette, V Doudenkova, ...
BioéthiqueOnline 5 (38), 1-5, 2016
22016
Art + Bioéthique : quand la recherche en bioéthique quitte les murs de l’université
V Couture, JC Bélisle-Pipon, M Laliberté
BioéthiqueOnline 5 (16), 2016
22016
Preparing for the arrival of “pink Viagra”: strengthening Canadian direct-to-consumer information regulations
JC Bélisle Pipon, B Williams-Jones
Canadian Medical Association Journal 188 (5), 319-320, 2016
2*2016
Visées éthiques, développement et usage du médicament
JS Fortin, JC Bélisle-Pipon, I Ganache
Précis de pharmacologie, 1011-1021, 2015
22015
Ethical challenges of open-access publishing
B Williams-Jones, JC Bélisle-Pipon, E Smith, R Boulanger
University Affairs, 2014
22014
“What Is PER?” Patient Engagement in Research as a Hit
JC Bélisle-Pipon, C Del Grande, G Rouleau
Canadian Journal of Bioethics 1 (2), 59-62, 2018
12018
Dear DTCA, Please Don’t Deceive Me, Don’t Play on My Fantasy
JC Bélisle-Pipon
BioéthiqueOnline 5, 2016
12016
Between Policy and Politics: When Bioethics Ventures into Public Debate
JCB Pipon, MÈ Lemoine, M Laliberté, B Williams–Jones
Narrative inquiry in bioethics 6 (1), 3-6, 2016
12016
Research ethics and commercial drug development: when integrity threatens profitability
JC Bélisle Pipon
BioéthiqueOnline 5, 2016
12016
Les enjeux éthiques de la limite des ressources en santé
J Saint-Arnaud, B Godard, JC Bélisle Pipon
Presses de l'Université de Montréal, 2016
12016
The system can't perform the operation now. Try again later.
Articles 1–20